MENU
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Exelixis (EXEL) Ownership - Who owns Exelixis?
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.26B
P/E Ratio
20.82
Total Cash
1.19B
Projected Growth
2.62
Total Debt
194.45M
Revenue
2.08B
Risk (Beta)
0.45
Dividend Yield
N/A
Total Cash/Share
4.25
Total Debt/Equity
479.87
Revenue/Share
7.32 USD as % of share price
Fundamentals
EXEL
Capitalization
10.3B
P/E Ratio
20.82
Risk (Beta)
0.45
Dividend Yield
N/A
Total Cash
1.19B
Total Cash/Share
4.25
Total Debt
194M
Total Debt/Equity
479.87
Projected Growth (PEG Ratio)
2.62
Revenue/Share (as % of the share price)
7.32%
Revenue
2.08B
ROE
N/A
Book Value
2.28B
P/B Ratio
4.57
Cash Flow
N/A
Earnings
1.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
286K
Current Ratio
3.93
Current Revenue Per Employee
411864.12
Dividends Per Share - Security
N/A
EBITDA
636M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.79
Revenue To Assets
15.73
Shares Held By Institutions
14.2B
Shares Outstanding - Current
280M
Total Liabilities
685M
Total Volume MTD
N/A
Value
-1
Gain YTD
10.060
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
1310
Web
https://www.exelixis.com